Article
Lung cancer: future directions.
Respirology (Carlton, Vic.) - 1 Jul 2007
Lam Wah K, Watkins D Neil
Abstract excerpt
Increasingly, basic research is being translated into clinical benefits for patients. Recent studies have shed more light on the clinical use of targeted therapies such as tyrosine kinase and angiogenesis inhibitors, and predictive factors for their clinical benefit and their role in different clinical settings are now being elucidated. New insights into the basic biology of lung cancer hold translational promise...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
